Member Info for Laura2022

NU

Miri was bust ENET isn't

MIRI did 350% 2 weeks ago and ENET not bust as Miri was

Right here

NT to buy

I'm up nearly 80% on LST which was similar situation to GNIP

Now up over 25% on a sizeable position:)

At 1.8p bid nearly approaching 100% up from investing

More

But NT for £2k

From Friday

Chuggly

I have a quick look and their posting history/often new ID tell a story

So I quickly filter

Chuggly

All my summaries are talen from Rns and are NOT A.I BTW

As for other "gang ups" kind to step in but I just filter and ignore

Best wishes

To buy before imminent RNS

Dr Sébastien Goudreau, Chief Scientific Officer of ImmuPharma, said:

"The initiation of IND-enabling activities represents an important step in advancing Kapiglucagon towards clinical development. By establishing a clear regulatory pathway, we aim to efficiently and cost-effectively progress the program towards first-in-human studies and position it for future partnering opportunities."

Mark Corbett, Chief Executive Officer of tranScrip, said:

"tranScrip is pleased to be working alongside ImmuPharma at this important stage of the Kapiglucagon program. By combining regulatory strategy with hands-on preparation for FDA interaction, we aim to help ImmuPharma move forward with clarity, confidence and momentum toward IND-enabling milestones."

Excellent news

ImmuPharma Initiates IND-Enabling Program for Kapiglucagon to treat Diabetes

ImmuPharma plc, (LSE AIM: IMM), the specialist drug discovery and development company, is pleased to announce the initiation of IND-enabling activities for its Kapiglucagon diabetes program, following the execution of a 'Work Order' with specialist pharmaceutical consultancy tranScrip Limited ("tranScrip").

Under the agreement, tranScrip will support the development of the regulatory strategy and the preparation and execution of a pre-IND meeting with the FDA, including the preparation of an integrated briefing package and IND planning activities.

The program is expected to progress through a streamlined development pathway, with ImmuPharma evaluating a 505(b)(2) regulatory approach in the United States, leveraging existing data on native glucagon, subject to FDA confirmation.

What a strange comment Charlie

Stick to PTAL GGP

Filtered

One minute its major re rate then its selling continues

Time waster

All of your posts , on a monthly basis, follow same pattern

Filtered

Paulb20

Posted in: QHE

Posts: 484

Beginning to think Something not Right here27 Jan 2026 15:54

The Selling has been relentless over the last few Months what the hell is going on.

Don't understand When 3D Results are Due this week ......someone knows something

Paulb20

Posted in: QHE

Posts: 484

3D Results due this week27 Jan 2026 14:56

Should see 3d results this week that will certainly Move the Share price Northwards Expecting good news

Paulb20

Posted in: QHE

Posts: 484

RE: Seller Keeping This Down26 Jan 2026 14:43

This selling has been going on for months

Paulb20

Posted in: QHE

Posts: 484

Excellent News26 Jan 2026 08:07

Major rerate underway now

Yeah...

Gluck

56mln

See all my posts and stated amount

:)

Paulb20

Posted in: QHE

Posts: 482

Sagebrush is Flowing Rumours3 May 2026 18:03

Lets hope that the Rumours are confirmed and it lands first thing Tues

Paulb20

Posted in: QHE

Posts: 482

Selling continues day after day1 May 2026 09:47

Not looking good